The genetics of paragangliomas

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Approximately one-third of paragangliomas have a genetic basis.
• Head and neck paragangliomas require genetic evaluation.

Purpose of the Study:

• To emphasize the importance of genetic testing in managing paraganglioma.
• To outline the implications of identifying genetic mutations.

Main Methods:

• Genetic testing for susceptibility genes (SDHD, SDHB, SDHC, SDHAF2, VHL).
• Clinical evaluation and family history assessment.
• Investigation for additional tumors and functional screening.

Main Results:

• Germline mutations in SDHB gene indicate high risk for malignancy and poor prognosis.
• Identification of mutations necessitates comprehensive screening for related tumors.
• Hereditary paraganglioma diagnosis enables predictive genetic screening in relatives.

Conclusions:

• Genetic testing is integral to the diagnosis and treatment of paraganglioma.
• Early identification of hereditary paraganglioma improves patient management and surveillance.
• SDHB mutations require vigilant monitoring due to associated risks.